Personal information

Other IDs

Scopus Author ID: 56986079600

Activities

Collapse all

Works (9)

Validation of a radiosynthesis method and a novel quality control system for [68 Ga]Ga-MAA: is TLC enough to assess radiopharmaceutical quality?

EJNMMI Radiopharmacy and Chemistry
2024-10-15 | Journal article
DOI: 10.1186/s41181-024-00302-x
Contributors: Silvia Migliari; Stefano Bruno; Annalisa Bianchera; Ilaria De Nardis; Antonio Scarano; Monica Lusardi; Anna Gaiani; Alessandra Guercio; Maura Scarlattei; Giorgio Baldari et al.
Source: check_circle
Crossref

PET and SPECT imaging as a solid guide to detect and discriminate atypical phenotypes of neurodegenerative disorders

European Journal of Clinical and Experimental Medicine
2024-03-30 | Journal article
DOI: 10.15584/ejcem.2024.1.20
Contributors: Livia Ruffini; Alessandro Zilioli; Veronica Cervati; Fulvio Lauretani; Francesco Misirocchi; Marcello Maggio; Silvia Migliari; Tiziano Graziani; Carla Cidda; Giorgio Baldari et al.
Source: check_circle
Crossref

High Prognostic Value of 68Ga-PSMA PET/CT in Renal Cell Carcinoma and Association with PSMA Expression Assessed by Immunohistochemistry

Diagnostics
2023-09-28 | Journal article
DOI: 10.3390/diagnostics13193082
Contributors: Donatello Gasparro; Maura Scarlattei; Enrico Maria Silini; Silvia Migliari; Giorgio Baldari; Veronica Cervati; Tiziano Graziani; Nicoletta Campanini; Umberto Maestroni; Livia Ruffini
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Scale down and optimized automated production of [68Ga]68Ga-DOTA-ECL1i PET tracer targeting CCR2 expression

EJNMMI Radiopharmacy and Chemistry
2023-02-02 | Journal article
DOI: 10.1186/s41181-023-00188-1
Contributors: Silvia Migliari; Maura Scarlattei; Giorgio Baldari; Livia Ruffini
Source: check_circle
Crossref

Scale down and optimized automated production of [68Ga]68Ga-DOTA-ECL1i PET tracer targeting CCR2 expression

2023-01-04 | Preprint
DOI: 10.21203/rs.3.rs-2369203/v1
Contributors: Silvia Migliari; Maura Scarlattei; Giorgio Baldari; Livia Ruffini
Source: check_circle
Crossref

A Specific HPLC Method to Determine Residual HEPES in [68Ga]Ga-Radiopharmaceuticals: Development and Validation

Molecules
2022-07-13 | Journal article
DOI: 10.3390/molecules27144477
Contributors: Silvia Migliari; Maura Scarlattei; Giorgio Baldari; Claudia Silva; Livia Ruffini
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Feasibility of a Scale-down Production of [68Ga]Ga-NODAGA-Exendin-4 in a Hospital Based Radiopharmacy

Current Radiopharmaceuticals
2022-03 | Journal article
DOI: 10.2174/1874471014666210309151930
Contributors: Silvia Migliari; Antonino Sammartano; Maura Scarlattei; Giorgio Baldari; Barbara Janota; Riccardo C. Bonadonna; Livia Ruffini
Source: check_circle
Crossref

Development and Validation of an Analytical HPLC Method to Assess Chemical and Radiochemical Purity of [68Ga]Ga-NODAGA-Exendin-4 Produced by a Fully Automated Method

Molecules
2022-01-15 | Journal article
DOI: 10.3390/molecules27020543
Contributors: Silvia Migliari; Antonino Sammartano; Marti Boss; Martin Gotthardt; Maura Scarlattei; Giorgio Baldari; Claudia Silva; Riccardo C. Bonadonna; Livia Ruffini
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A Rapid and Specific HPLC Method to Determine Chemical and Radiochemical Purity of [68>Ga]Ga-DOTA-Pentixafor (PET) Tracer: Development and Validation

Current Radiopharmaceuticals
2021-06-04 | Journal article
DOI: 10.2174/1874471013666200929125102
Contributors: Silvia Migliari; Antonino Sammartano; Maura Scarlattei; Giorgio Baldari; Claudia Silva; Livia Ruffini
Source: check_circle
Crossref
How many people are using ORCID?